Overview

Depakote-ER for Depressive and Bipolar Depression

Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
Obtain information using a randomized treatment to assess the antidepressant and anxiolytic efficacy of divalproex vs. placebo for nonrefractory bipolar patients with major depressive episodes.
Phase:
Phase 4
Details
Lead Sponsor:
Cambridge Health Alliance
Collaborator:
Northwestern University
Treatments:
Valproic Acid